ZA955537B - New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for rar-alpha and their uses - Google Patents

New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for rar-alpha and their uses

Info

Publication number
ZA955537B
ZA955537B ZA955537A ZA955537A ZA955537B ZA 955537 B ZA955537 B ZA 955537B ZA 955537 A ZA955537 A ZA 955537A ZA 955537 A ZA955537 A ZA 955537A ZA 955537 B ZA955537 B ZA 955537B
Authority
ZA
South Africa
Prior art keywords
ligand specific
alpha
rar
rxrs
compositions based
Prior art date
Application number
ZA955537A
Other languages
English (en)
Inventor
Serge Michel
Christine Cathelineau
Marie-Cecile Lenoir-Viale
Michel Demarchez
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Publication of ZA955537B publication Critical patent/ZA955537B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Catalysts (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
ZA955537A 1994-07-27 1995-07-04 New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for rar-alpha and their uses ZA955537B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9409307A FR2722985B1 (fr) 1994-07-27 1994-07-27 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand specifique des rxrs et au moins un ligand specifique de rar-x ou de vdr, et leurs utilisations

Publications (1)

Publication Number Publication Date
ZA955537B true ZA955537B (en) 1996-02-16

Family

ID=9465802

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA955537A ZA955537B (en) 1994-07-27 1995-07-04 New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for rar-alpha and their uses

Country Status (19)

Country Link
US (1) US5767148A (pt)
EP (1) EP0694301B1 (pt)
JP (1) JP2783521B2 (pt)
KR (1) KR0168727B1 (pt)
AT (1) ATE145134T1 (pt)
AU (1) AU674479B2 (pt)
BR (1) BR9502338A (pt)
CA (1) CA2154730C (pt)
DE (1) DE69500085T2 (pt)
ES (1) ES2098164T3 (pt)
FI (1) FI953567A (pt)
FR (1) FR2722985B1 (pt)
HU (1) HUT73793A (pt)
IL (1) IL114765A (pt)
NO (1) NO952944L (pt)
NZ (1) NZ272527A (pt)
PL (1) PL181061B1 (pt)
RU (1) RU2120304C1 (pt)
ZA (1) ZA955537B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735367B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Utilisation de ligands specifiques des recepteurs rxrs
FR2735370B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes agonistes des recepteurs rxrs
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
FR2753091B1 (fr) * 1996-09-09 2001-03-16 Oreal Utilisation d'un agoniste des recepteurs des retinoides de type rxr pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
JP2001522350A (ja) * 1997-04-11 2001-11-13 シドニー キメル キャンサー センター 疾患におけるエンドセリン−1の過剰産生の阻害のためのレチノイド関連分子
JP2001511445A (ja) * 1997-07-29 2001-08-14 ブリストル−マイヤーズ スクイブ カンパニー 外科手術による癒着を予防するための選択性r×rアゴニストの使用
FR2779720B1 (fr) * 1998-06-12 2002-08-16 Galderma Rech Dermatologique Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
US6904229B1 (en) * 1999-08-20 2005-06-07 Canon Kabushiki Kaisha Apparatus for recording signals on disk recording medium
CN100388532C (zh) * 2005-09-28 2008-05-14 浙江工业大学 一种锂二次电池的隔膜添加剂及锂二次电池隔膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE208194T1 (de) * 1991-08-23 2001-11-15 Salk Inst For Biological Studi Verwendung von selektiven liganden zur behandlung von hormonansprechenden krankheitzuständen
AU675430B2 (en) * 1992-04-22 1997-02-06 Ligand Pharmaceuticals Incorporated Compounds having selectivity for retinoid X receptors

Also Published As

Publication number Publication date
PL309772A1 (en) 1996-02-05
ATE145134T1 (de) 1996-11-15
AU2327995A (en) 1996-02-08
CA2154730A1 (fr) 1996-01-28
CA2154730C (fr) 2000-02-15
IL114765A0 (en) 1995-11-27
NZ272527A (en) 1997-01-29
BR9502338A (pt) 1996-02-27
JPH0859511A (ja) 1996-03-05
NO952944L (no) 1996-01-29
FI953567A (fi) 1996-01-28
HU9502241D0 (en) 1995-09-28
JP2783521B2 (ja) 1998-08-06
KR960003721A (ko) 1996-02-23
FR2722985A1 (fr) 1996-02-02
EP0694301A1 (fr) 1996-01-31
PL181061B1 (pl) 2001-05-31
EP0694301B1 (fr) 1996-11-13
NO952944D0 (no) 1995-07-25
ES2098164T3 (es) 1997-04-16
KR0168727B1 (ko) 1999-01-15
HUT73793A (en) 1996-09-30
RU2120304C1 (ru) 1998-10-20
IL114765A (en) 2000-06-01
AU674479B2 (en) 1996-12-19
FR2722985B1 (fr) 1996-09-13
DE69500085T2 (de) 1997-03-06
DE69500085D1 (de) 1996-12-19
FI953567A0 (fi) 1995-07-26
US5767148A (en) 1998-06-16

Similar Documents

Publication Publication Date Title
ATE197763T1 (de) Zusammensetzungen, welche ein rar alpha spezifischer liganden und mindestens eine fettsäure enthalten
AU8109794A (en) 7h-imidazo(1,2-a)pyrazine-8-one nmda receptor antagonists
MY119073A (en) Adjustable double deck elevator
AU628430B2 (en) Apparatus and method for determining the tension on a ligament graft
AU9777098A (en) Web based integrated customer interface for invoice reporting
FI942276A (fi) Irrotettavissa oleva tulppakäämikokoonpano
ZA955537B (en) New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for rar-alpha and their uses
HK1039477A1 (en) 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
ES2179168T3 (es) Utilizacion de un ligando especifico de los receptores rxr.
AU4643096A (en) Novel trienoic retinoid compounds and methods
DK0657106T3 (da) Hydrogenerede fructooligosaccharider
ES1009885U (es) Equipo de afeitado.
HK1006354A1 (en) Dimmer fault reporting
AU4607696A (en) Tricyclic retinoids, methods for their production and use
AU4071897A (en) Nmda (n-methyl-d-aspartate) antagonists
EP0638364A3 (de) Testbesteck.
ATE163250T1 (de) Futtermischwagen
AU4035889A (en) Retinoic acid receptor
EP0641533A3 (de) Sitz eines Operateurstuhles.
FR2722094B1 (fr) Composition orale pour reactiver le bronzage de lapeau a base d'un carotenoide et d'un tocopherol
DE69117729D1 (de) Vorrichtung für die abnehmbare Verbindung von zwei Elementen
Potter Primary resource configuration effects on secondary resource use by ring-billed gull populations in two landscapes.
DE59807868D1 (de) Presse mit dosieranlage
Risopoulos Science et technique au service du développement
Joron Trait (é) du Moi-peau: impressions en art-thérapie